The CRISP Trial IIB

A phase IIB trial of a colorectal cancer risk tool to optimize screening in primary care

Colorectal cancer (CRC) is a major health problem in Australia. Despite this, many higher risk patients are not having colonoscopies when they should and many average risk patients are being over-screened with colonoscopies. The Phase IIB CRISP trial is a multi-site randomised controlled trial which aims to measure the efficacy of the CRISP ‘Colorectal cancer RISk Prediction tool’ on rates of ‘appropriate’ colorectal cancer screening when delivered in a standardised way by a research nurse in general practice.

Current status:

Funded, in recruitment

For more information contact:

Trial coordinator Dr. Jennifer Walker, Department of General Practice, The University of Melbourne (walker@unimelb.edu.au, +61 3 8559 7408)